http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05271187-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
| filingDate | 1993-01-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-10-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H05271187-A |
| titleOfInvention | Pyrrolidine derivative or pharmaceutically acceptable salt thereof |
| abstract | (57) [Summary] (Modified) [Object] To provide a pyrrolidine derivative of the formula (1) having inhibitory activity against prolyl endopeptidase, serine protease, and thiol protease. [Structure] A pyrrolidine derivative of the formula (1) or a pharmaceutically acceptable salt thereof and an intermediate for the production thereof, a compound of the formula (2). [Wherein X is (1) (substituted) benzoyl group, (2) (substituted) cycloalkylcarbonyl group, (3) lower alkylcarbonyl group, (4) (substituted) phenylmethyloxycarbonyl group, or (5) ( (Substituted) phenyl lower alkylcarbonyl group, Y is (1) lower alkyl group, (2) cycloalkyl group, (3) (substituted) phenyl group, Or (4) represents a (substituted) phenyl lower alkyl group, provided that when X is (5), Y is (2). [Effect] The compound of the present invention is expected as an active ingredient of an antiamnestic drug. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965556-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9503277-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756763-A |
| priorityDate | 1992-01-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 141 of 141.